NCT00005112View on ClinicalTrials.gov

Growth Hormone Use in Cystic Fibrosis - a Multicenter Study

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Cystic Fibrosis

Interventions

DRUG

Human recombinant growth hormone

Trial Locations (2)

77030

University of Texas Medical School, Houston

84132

University of Utah, Dept of Pediatric Endocrinology, Salt Lake City

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

National Center for Research Resources (NCRR)

NIH

NCT00005112 - Growth Hormone Use in Cystic Fibrosis - a Multicenter Study | Biotech Hunter | Biotech Hunter